Zoetis (ZTS) Invested Capital (2012 - 2026)
Zoetis' (ZTS) quarterly Invested Capital came in at $12.2 billion in Q2 2026, up 3.88% year-over-year from $11.7 billion in Q2 2025, and down 0.67% quarter-over-quarter from $12.3 billion in Q1 2026.
Analysis
Zoetis (ZTS) Invested Capital (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Invested Capital for 15 consecutive years, with $12.2 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Invested Capital rose 3.88% year-over-year to $12.2 billion in Q2 2026; TTM through Jun 2026 was $12.2 billion, a 3.88% increase from a year earlier, with the FY2025 full-year figure at $12.5 billion, down 0.9% from the prior year.
- Invested Capital was $12.2 billion for Q2 2026 at Zoetis, down from $12.3 billion in the prior quarter.
- Over five years, Invested Capital peaked at $12.6 billion in Q1 2025 and troughed at $11.1 billion in Q1 2023.
- A 5-year average of $11.7 billion and a median of $11.6 billion in 2023 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital rose 10.52% in 2022 and decreased 6.06% in 2023, its largest moves.
- Over 5 years, Invested Capital stood at $12.3 billion in 2022, then decreased by 6.06% to $11.6 billion in 2023, then dropped by 1.27% to $11.4 billion in 2024, then grew by 9.14% to $12.5 billion in 2025, then fell by 2.1% to $12.2 billion in 2026.
- The last three Invested Capital figures came in at $12.2 billion (Q2 2026), $12.3 billion (Q1 2026), and $12.5 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 2.43 Bn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 12.20 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 10.51 Bn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 1.00 Bn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 41.18 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 53.77 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 542,702.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.20 Bn |
| Mar 31, 2026 | 12.28 Bn |
| Dec 31, 2025 | 12.46 Bn |
| Sep 30, 2025 | 12.47 Bn |
| Jun 30, 2025 | 11.74 Bn |
| Mar 31, 2025 | 12.58 Bn |
| Dec 31, 2024 | 11.41 Bn |
| Sep 30, 2024 | 11.81 Bn |
| Jun 30, 2024 | 11.52 Bn |
| Mar 31, 2024 | 11.66 Bn |
| Dec 31, 2023 | 11.56 Bn |
| Sep 30, 2023 | 11.63 Bn |
| Jun 30, 2023 | 11.18 Bn |
| Mar 31, 2023 | 11.06 Bn |
| Dec 31, 2022 | 12.31 Bn |
| Sep 30, 2022 | 11.23 Bn |
| Jun 30, 2022 | 11.15 Bn |
| Mar 31, 2022 | 11.24 Bn |
| Dec 31, 2021 | 11.14 Bn |
| Sep 30, 2021 | 11.27 Bn |